Huberman Lab avatar

Dexa/Huberman Lab

Supported byHuberman Lab
Learn more

Ketamine and Depression

Ketamine and similar dissociative anesthetics are showing promise in treating depression by inducing a separateness from grief and emotions. This intriguing effect may stem from their ability to block the NMDA receptor, which is traditionally associated with neural activation and plasticity. Despite the experimental nature of these treatments, many individuals report significant relief from depressive symptoms with fewer sessions than expected.
  • In this clip

  • From this podcast

    Huberman Lab avatar

    Huberman Lab

    Understanding & Conquering Depression | Huberman Lab Podcast #34

  • Related Questions

    • How does the NMDA receptor work in the context of ketamine's effects on depression, PTSD, and neuroplasticity as discussed in the episode "Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast" and the clip "Neural Circuits of Depression"?

    • How does the NMDA receptor work in the context of ketamine's effects on depression, PTSD, and neuroplasticity as discussed in the episode Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast and the clip Neural Circuits of Depression?

    • How does the NMDA receptor work in the context of ketamine's effects on depression, PTSD, and neuroplasticity as discussed in the episode Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast and the clip Neural Circuits of Depression?

Built by
Charlie AI
© 2024 Huberman LabTermsPrivacyDisclaimerSupport